Kyverna Therapeutics

About Kyverna Therapeutics

Kyverna Therapeutics is a clinical-stage biotechnology company developing cell therapies for autoimmune diseases. The company focuses on creating engineered CAR T-cell therapies that target and eliminate pathogenic B cells responsible for conditions like lupus and multiple sclerosis. Their primary customers are patients suffering from autoimmune disorders, and they collaborate with healthcare providers and research institutions. While maintaining a hybrid work model, Kyverna emphasizes scientific collaboration and innovation in their distributed teams.

Company Culture

Kyverna fosters a collaborative and mission-driven culture focused on scientific excellence and patient impact. The company encourages cross-functional teamwork between research, clinical, and operational teams to advance their therapies. Employees describe a fast-paced environment with opportunities for professional growth and meaningful contributions to groundbreaking medical research.

Our Values

Patient-first approach, scientific rigor, innovation in cell therapy, collaborative teamwork, integrity in research, and commitment to improving autoimmune disease treatments.

Benefits & Perks

Kyverna offers comprehensive health benefits including medical, dental, and vision coverage. Employees receive competitive compensation packages with equity participation and opportunities for professional development. The company supports a hybrid work model with flexible scheduling and provides resources for remote collaboration.

Roles & Teams We Hire For

Skills & Tools You'll Use

Open Positions (3)